The fact-finding survey on Shared Decision Making(SDM)/Measurement Based Care(MBC)in the treatment of depression

The fact-finding survey on Shared Decision Making(SDM)/Measurement Based Care(MBC)in the treatment of depression - The survey on SDM/MBC in the treatment of depression

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054220

Enrollment

500

Registered

2024-04-26

Start date

2024-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All of the following conditions must be met Phycisian; Physicians registered on the Epoca Marketing Inc. research panel at the start of the survey Physicians who have treated at least 10 patients with depression in the last month Physicians who have given written consent to this survey Patients; Patients with an ICD-10 or DSM-IV/DSM-5 diagnosis of depression and informed by their own physicians Patients aged 18 years or older who are being treated with antidepressant medication Patients who have given written consent to the study

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
1. Tabulation of each answer 2. Tabulation of the following items Cross-tabulation of SDM/MBC implementation and responses of physicians and patients to the following items (content and comprehension of explanations regarding depression treatment, content and comprehension of explanations regarding antidepressants, treatment satisfaction, communication status, comprehension and satisfaction, SDM implementation status and needs, and rating scale use status and needs, etc.)	—

Measure

Time frame

1. Tabulation of each answer 2. Tabulation of the following items Cross-tabulation of SDM/MBC implementation and responses of physicians and patients to the following items (content and comprehension of explanations regarding depression treatment, content and comprehension of explanations regarding antidepressants, treatment satisfaction, communication status, comprehension and satisfaction, SDM implementation status and needs, and rating scale use status and needs, etc.)

—

Countries

Japan

Contacts

Public ContactKazuo Aoki

Otsuka Phamacetutical Co., Ltd Department of Medical Affairs

aoki.kazuo@otsuka.jp03-6717-1400

Outcome results